Tuberculosis: Drugs
(asked on 7th November 2022) - View Source
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to encourage pharmaceutical companies, in particular Sanofi, to (1) licence, and (2) register, new medications for tuberculosis in England, in particular Rifapentine.
This question was answered on 22nd November 2022
Suppliers, such as Sanofi, will determine whether to apply for a marketing authorisation for a new medicine from the Medicines and Healthcare products Regulatory Agency (MHRA). For an authorisation to be granted for a medicine, the MHRA must receive a full marketing application from the applicant.